Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

The document says to treat cat fungal infections with medicine and clean the environment, noting that cats without symptoms can still spread it to humans.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.